The company is preparing for a pre-IND meeting with the FDA to discuss the development of STI2832.
Steptoe Therapeutics is planning to conduct next Advisory Board during Q1 2017. Several members of the Advisory Board
have confirmed their availability to participate. They have initially evaluated the merits of our work and they are willing
to collaborate in the development of this product candidate.
Carlos E. Sueldo, MD FACOG
is a gynecologist specialized in Reproductive Endocrinology. He is currently Chair at the Department of Obstetrics and Gynecology
at University of California, San Francisco at Fresno. Dr. Sueldo is a reproductive endocrinologist at Women's Specialty &
Fertility Center, Clovis, CA. He is graduated from University of Buenos Aires School of Medicine and he completed his residency
in Chicago, IL. He has published in major journals of the specialty and collaborated in several original research projects.